Physician

Dina Joseph Tebcherany, MD

According to 2025 Medicare claims, Dina Tebcherany, MD (NPI: 1578501664) practices medical oncology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Travis, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1972770303; TIN: 752131429) and primary practice location at 78745-1145.

Tebcherany's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 507 traditional Medicare patients, billed 258,865 HCPCS/CPT codes, and received $4,954,148 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 987 prescription claims across 158 beneficiaries totaling $1,018,584 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 19 claims. Open Payments data shows 3 records totaling $113. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $894,455 to $4,954,148. Similarly, Part D prescription costs have risen steadily, from $146,370 to $1,018,584. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.2M2015 Medicare payment: $894,455 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,327,954 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,136,911 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,663,263 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,073,138 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,861,726 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,182,801 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,150,472 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,568,098 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,954,148 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201522243,998$894,455
201638290,819$1,327,954
2017504154,526$2,136,911
2018530162,871$2,663,263
2019565242,016$3,073,138
2020553241,189$3,861,726
2021538250,847$4,182,801
2022560324,171$5,150,472
2023535288,811$4,568,098
2024507258,865$4,954,148

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$538K$1.1M2015 Drug cost: $146,370 (USD; Tot_Drug_Cst)2016 Drug cost: $191,972 (USD; Tot_Drug_Cst)2017 Drug cost: $370,669 (USD; Tot_Drug_Cst)2018 Drug cost: $498,485 (USD; Tot_Drug_Cst)2019 Drug cost: $343,393 (USD; Tot_Drug_Cst)2020 Drug cost: $770,266 (USD; Tot_Drug_Cst)2021 Drug cost: $1,075,310 (USD; Tot_Drug_Cst)2022 Drug cost: $1,067,587 (USD; Tot_Drug_Cst)2023 Drug cost: $664,929 (USD; Tot_Drug_Cst)2024 Drug cost: $1,018,584 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201577349$146,370
201687445$191,972
201797519$370,669
2018114553$498,485
2019109524$343,393
2020130738$770,266
2021143843$1,075,310
2022174931$1,067,587
2023154840$664,929
2024158987$1,018,584

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.5K$5.0K2015 Medicare payment: $4,975 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $974 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R35$4,975
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R19$974

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less163617$104
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more156389$95
80053Blood test, comprehensive group of blood chemicals180683$10
36415Insertion of needle into vein for collection of blood sample185834$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count184745$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate14420$226,006
GleevecImatinib Mesylate13390$135,539
LonsurfTrifluridine/Tipiracil Hcl12336$91,164
EliquisApixaban502,740$51,175
XareltoRivaroxaban311,590$28,091

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0656Segmental pneumatic appliance for use with pneumatic compressor, trunkYN/R19$974

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$113Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Dina Joseph Tebcherany, MD?

Tedicare shows public-source Medicare data for Dina Joseph Tebcherany, MD (NPI 1578501664), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dina Joseph Tebcherany, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dina Joseph Tebcherany, MD?

Dina Joseph Tebcherany, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1972770303) in the available physician profile data.

Does Dina Joseph Tebcherany, MD have Open Payments data?

Dina Joseph Tebcherany, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.